CLINICAL ROLE -
Environmental Chemicals Linked to Breast Cancer Risk
Exposure to many chemicals, including gasoline, can heighten the risk of developing breast cancer.
Read More
CVS Launches New Performance-Based PBM Network
New network encourages medication adherence for chronic conditions.
EGFR Signaling Could be Harnessed to Fight Cancer
New discovery about EGFR signaling may prevent cancer cells from spreading.
Insufficient Sleep May Lead to Gestational Diabetes
Pregnant women who slept less than 6.5 hours per night were nearly 3 times as likely to develop gestational diabetes.
Trending News Today: Investigation Targets Insulin Manufacturers, PBMs
Top news of the day from across the healthcare landscape.
Trending News Today: House Plans to Vote on CHIP Funding Bill
Fingolimod Effective Against Multiple Sclerosis Relapse in Pediatric Patients
Fingolimod shows 82% efficacy reducing the annualized multiple sclerosis relapse rate.
Endometriosis Pain Drug Gets FDA Priority Review
Elagolix is an orally administered gonadotropin-releasing hormone or GnRH antagonist for endometriosis with associated pain.
Minimalism Eliminates Excess and Creates Freedom in Your Life and Career
Having lots of possessions isn’t wrong, but research demonstrates that possessions don’t equal happiness.
4 of the Top Stories in Pharmacy From October
American Pharmacists Month has seen a ton of change in the profession.
Thoughts About CVS Health and Aetna
CVS Health has reportedly placed a bid to buy Aetna, one of the nation’s largest health insurers.
New Pharmacy Benefit Manager Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Week in Review: October 27, 2017
A look at last week's top stories in the world of pharmacy.
Study: Engaged Employers More Satisfied with Their PBMs
Analysis shows that more engaged employers work diligently with their pharmacy benefit managers to assure alignment between services and total value.
Employers and PBMs: Where do They Stand on Prescription Drug Issues?
Employers provide coverage for 56% of the insured population, which carries significant weight with pharmacy benefit managers.
ACA Silver Plan Premiums Projected to Increase 34% in 2018
Market instability contributes to increasing premiums for 2018 Affordable Care Act health plans.
DIR Fees White Paper Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
Gene Therapy-Immunotherapy Combination Could Reverse Multiple Sclerosis
Combination therapy found to reverse multiple sclerosis in mice models.
Protein Deletion May Eliminate Diabetes Risk
Deleting fatty acid-binding proteins may lead to lifelong metabolic health.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Trending News Today: Trump Declares Opioid Epidemic a Public Health Emergency
Trending News Today: Amazon Receives Pharmacy License in 12 States
Plaque Psoriasis Drug Shows Strong Efficacy Versus Competitors
Risankizumab treats moderate to severe chronic plaque psoriasis.
Single Tablet HIV Regimen Shows Promise
Once-daily HIV treatment found to be highly effective and well-tolerated in treating antiretroviral-naïve HIV-1 patients.
ACIP Makes Recommendations for Changes to 2018 Immunization Schedules
One update reflects the committee’s recommendation of a third dose of mumps-containing vaccine in mumps outbreak settings, as determined by public health authorities.
Pharmacy Times Editor Shares Personal Story, Thanks Her Pharmacist for Helping
As part of American Pharmacists Month, an editor shares her story of how a pharmacist helped her through a scary drug reaction.
Watch
Biosimilars Could Save $54 Billion Over the Next Decade
The emergence of biosimilars will reduce spending on biologics by 3% through 2027.
FDA Approves Treatment for Chemotherapy-Induced Nausea and Vomiting
Varubi indicated for use in combination with other antiemetic agents to treat delayed chemotherapy-induced nausea and vomiting in adults.
Study: Hospitals Mark-Up Drugs Significantly
Drugs administered in an outpatient setting may be marked-up more than 500%.
PI3K Inhibitors Promising for Rare Bone Cancer Therapy
Genome analysis points to potential new treatments for patients with chordoma.